Studies have explored its expression characteristics and biological functions in low-grade glioma cohorts, finding that SERPINE1 can not only serve as a prognostic biomarker but also as a potential therapeutic target for glioma (22). The gene discussed is SERPINE1; the disease is central nervous system cancer.